Analysts Have Lowered Expectations For Aadi Bioscience, Inc. After Its Latest Results - Simply Wall St
AADI Stock | USD 2.36 0.02 0.85% |
Under 51% of Aadi Bioscience's traders are presently thinking to get in. The analysis of the overall investor sentiment regarding Aadi Bioscience suggests that some traders are interested. Aadi Bioscience's investing sentiment shows overall attitude of investors towards Aadi Bioscience.
Aadi |
Analysts Have Lowered Expectations For Aadi Bioscience, Inc. After Its Latest Results Simply Wall St
Read at news.google.com
Aadi Bioscience Investor Sentiment by Other News Outlets
Investor sentiment, mood or attitude towards Aadi Bioscience can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Aadi Bioscience Fundamental Analysis
We analyze Aadi Bioscience's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Aadi Bioscience using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Aadi Bioscience based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Revenue
Revenue Comparative Analysis
Aadi Bioscience is currently under evaluation in revenue category among its peers. Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.
Aadi Bioscience Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Aadi Bioscience stock to make a market-neutral strategy. Peer analysis of Aadi Bioscience could also be used in its relative valuation, which is a method of valuing Aadi Bioscience by comparing valuation metrics with similar companies.
Peers
Aadi Bioscience Related Equities
ERAS | Erasca | 12.94 | ||||
MLYS | Mineralys Therapeutics, | 5.64 | ||||
DSGN | Design Therapeutics | 4.67 | ||||
KURA | Kura Oncology | 1.45 | ||||
RZLT | Rezolute | 1.19 | ||||
AVTE | Aerovate Therapeutics | 1.14 | ||||
ANEB | Anebulo Pharmaceuticals | 0.70 | ||||
CRNX | Crinetics Pharmaceuticals | 0.33 | ||||
RARE | Ultragenyx | 0.06 | ||||
GLUE | Monte Rosa | 1.35 | ||||
ACRV | Acrivon Therapeutics, | 1.85 | ||||
ANAB | AnaptysBio | 2.32 | ||||
ARVN | Arvinas | 3.74 | ||||
ANTX | AN2 Therapeutics | 4.19 | ||||
ADAG | Adagene | 6.41 | ||||
RVMD | Revolution Medicines | 10.46 |
Complementary Tools for Aadi Stock analysis
When running Aadi Bioscience's price analysis, check to measure Aadi Bioscience's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Aadi Bioscience is operating at the current time. Most of Aadi Bioscience's value examination focuses on studying past and present price action to predict the probability of Aadi Bioscience's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Aadi Bioscience's price. Additionally, you may evaluate how the addition of Aadi Bioscience to your portfolios can decrease your overall portfolio volatility.
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA |